Home
Forums
New Posts
Illini Basketball
Illini Football
Sports Talk
Log in
Register
What's new
Menu
Log in
Register
Install the app
Install
Forums
General
Chat
Trading Stock/Investing
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="DaytonIllini" data-source="post: 1041497"><p>Pharmacyclics (PCYC) will be presenting updated data on its drug Imbruvica at the American Society of Hematology Dec 6-9. I own the stock here (up 10% since August) but this meeting could be a catalyst up or down for the stock. If you bought it and it's a substantial part of your portfolio you should be aware. It's just about 0.5% of mine so I am going to let it ride but if it was a bigger component I would probably take some gains and lighten my position. I am fairly conservative though.</p></blockquote><p></p>
[QUOTE="DaytonIllini, post: 1041497"] Pharmacyclics (PCYC) will be presenting updated data on its drug Imbruvica at the American Society of Hematology Dec 6-9. I own the stock here (up 10% since August) but this meeting could be a catalyst up or down for the stock. If you bought it and it's a substantial part of your portfolio you should be aware. It's just about 0.5% of mine so I am going to let it ride but if it was a bigger component I would probably take some gains and lighten my position. I am fairly conservative though. [/QUOTE]
Verification
Post reply
Forums
General
Chat
Trading Stock/Investing
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…